Explore the latest insights into the long-term outcomes of patients undergoing tissue-sparing posterior cervical fusion as a revision for 1-level pseudarthrosis following Anterior Cervical Discectomy and Fusion (ACDF). This blog post delves into the significance of this surgical approach, its impact on patient recovery, and how it contributes to the evolving landscape of Pain Medicine.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Long-term outcomes in patients treated with tissue-sparing posterior cervical fusion to revise a 1-level pseudarthrosis following ACDF.
Haglund et al., J Clin Neurosci 2023
DOI: 10.1016/j.jocn.2023.11.020
Study Overview: This observational study evaluated the long-term outcomes of patients who underwent tissue-sparing posterior cervical fusion (PCF) to treat symptomatic pseudarthrosis, a complication of anterior discectomy and fusion (ACDF).
Key Findings:
- The revision procedure took a median of 49 minutes, with an estimated blood loss of 10 cc.
- Patients were discharged a median of 1 day after treatment, with no instances of hospital readmission or further surgical interventions.
- At a median follow-up of 39 months, surgeons diagnosed complete fusion in 91% of cases, and an independent lab identified bridging bone in 80% of cases.
- Range of motion was less than 2° in 93% of cases.
- 74% of patients reported satisfaction with their outcomes.
Significance: The results suggest that tissue-sparing PCF can achieve similar rates of arthrodesis as open PCF, but without the extensive soft tissue dissection that can lead to perioperative morbidity and long-term pain. This could represent a significant advancement in the treatment of pseudarthrosis following ACDF.